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Abstract 
Bone Morphogenetic protein (BMP) signaling regulates lymphopoiesis in bone 
marrow and thymus via the interaction of hemato-lymphoid progenitors with the 
stroma microenvironment. Despite increasing functional evidence for the role of Bmp 
signaling in lymphopoiesis, little is known on the spatial distribution of Bmp/Bmp 
antagonists in the thymus and how Bmp signals exerts specific functions in 
developing lymphocytes. We analyzed expression of Bmp/Bmp antagonists in the 
thymus and bone marrow and determined the topology of Bmp/Bmp antagonist 
expression using lacZ reporter mice. Bmp4, Bmp7, Gremlin, and Twisted gastrulation 
(Twsg1) are all expressed in the thymus and expression was clearly different for each 
gene investigated. Expression was seen both in cortical and medullary regions 
suggesting that Bmp signals regulate all stages of T-cell development. Two genes in 
particular, Bmp7 and Twsg1, were dynamically expressed in developing T- and B-
lymphocytes. Their conditional ablation in all hematopoietic cells surprisingly did not 
affect the steady state of B- and T-cell development. This indicates that both 
lymphoid cell-derived BMP7 and TWSG1 are dispensable for normal lymphopoiesis 
and that bone-marrow stroma derived TWSG1 is responsible for the lymphoid defects 
observed in Twsg1 null mice. In summary our data demonstrate a complex network of 
lymphoid and stroma derived Bmp signals involved in the orchestration of 
lymphopoiesis in both bone marrow and thymus. 
 
 
 
 
Introduction 
Both T- and B-lymphocytes originate from a common lymphoid precursor but their 
development requires distinct microenvironments. B-lymphocytes develop in the bone 
marrow whereas T-cells mature in the thymus. It is well established that reciprocal 
interactions between developing lymphocytes and stroma cells from the respective 
organs are key to their successful maturation 1, 2. Several growth and differentiation 
factors have been identified in stromal cells that are instrumental for supporting T-cell 
and B-cell development 3, 4. However, less is known about signals that originate from 
the developing lymphocytes to reciprocally support stromal cell function 5.  
Embryonic development and adult homeostasis of most tissues are orchestrated to a 
large degree by only a few families of conserved signaling factors: the Hedgehog 
(Hh)-, Notch-, Wnt/ß-catenin-, Tumor-Growth-Factor (TGF)/Bone Morphogenetic 
Protein (BMP)-, and Fibroblast Growth Factor (FGF) families. All these signaling 
pathways are also important for the development of the lymphoid organs and 
lymphocytes themselves 6-9. 
Bmps, which belong to the TGFβ superfamily, are evolutionary highly conserved 
molecules and can be separated into two subgroups. Bmp2 and Bmp4 are orthologues 
of Drosophila Decapentaplegic (Dpp), whereas Bmp5, Bmp6, and Bmp7 belong to 
the Glass-bottom-boat (Gbb) subgroup. The name Bmp originates from the 
molecule’s ability to induce ectopic bone formation 10. Bmps are secreted signaling 
molecules and, contrary to their name, have critical functions in many different 
biological processes outside of bone formation. They are involved in many aspects of 
embryonic development 11, 12, homeostasis and repair of various tissues 13 including 
the hematopoietic system 14, 15.  
Bmps signal via specific heterodimeric Bmp receptors consisting of a type I receptor 
(Alk1, Alk2, Alk3, Alk6) and a type II receptor (BmpRII, ActRII, ActRIIB) subunit. 
Receptor engagement leads to the phosphorylation of a type I receptor by a type II 
receptor, which in turn facilitates the activation of either the BMP-specific Smad1/5/8 
signaling pathway 16 or non-specific signal transduction pathways such as 
MAPK/PI3K/Akt 17. In Smad-dependent signaling, Smad1/5/8 are phosphorylated and 
translocated together with the co-Smad Smad4 to the nucleus to exert their cellular 
effects 18.  
Receptor engagement by Bmps is highly regulated in the extracellular space by 
secreted Bmp antagonists such as Gremlin, Noggin, Chordin, and Twisted 
Gastrulation (TWSG1) that bind Bmps with high affinity and thus prevent receptor 
engagement 19. The binding affinities of the various Bmps to antagonists as well as 
receptors differ 20. Thus, the various Bmps and Bmp antagonists are not simply 
redundant but are required for the precise spatiotemporal regulation of Bmp signaling. 
By controlling Bmp expression as well as exploiting the different binding affinities to 
receptors and antagonists 20, a precise spatio-temporal regulation of Bmp signals is 
possible. Because of this complexity, the precise contribution of these different Bmp 
signals to complex biological processes is still poorly understood.  
Bmp signaling plays a prominent role during hematopoiesis: it modulates the 
developmental program of human hematopoietic stem cells (HSC) 14, 15 and controls 
the size and number of the HSC niches 21. Deregulation of Smad molecules affects 
normal hematopoietic growth and leads to neoplastic hematopoiesis 22.  
Bmp signals also regulate thymopoiesis 6, 23, 24 and the development of thymocytes 
themselves 25-28. Thymocyte development requires reciprocal interactions between 
thymic stroma and developing thymocytes 29. Similarly, B-cell development requires 
reciprocal interactions between developing B-lymphocytes and bone marrow stroma 5. 
Previous studies have shown that thymic stroma derived Bmp2/4 inhibits T cell 
development 25-27. Thymocytes can modulate the effect of Bmp2/4 by expressing the 
evolutionarily conserved Bmp modifier Twsg1 in a TCR-dependent manner 26, 30. 
Known target genes of Smad-dependent signaling are the inhibitor of differentiation 
(Id) gene family 31. Id proteins are important regulators of lymphocyte development 32 
lending further evidence for an important role of Bmp signals in coordinating 
lymphocyte development. 
In this study, we have mapped the site of expression for several Bmp and Bmp 
antagonists in the mouse thymus, as well as in subsets of developing T- and B-
lymphocytes and examined the effects of conditional ablation of these two molecules 
in developing lymphocytes.   
 
 
 
MATERIALS AND METHODS 
 
Mice 
Heterozygote Bmp4+/lacZ 33, Bmp7+/lacZ 34, gremlin+/lacZ 35, and Twsg1+/lacZ 36 reporter 
mice have been used in this study. Mice carrying conditional allele (Twsg1fl/+) 37 were 
crossed with FlpCre mice to remove the neo cassette and were subsequently 
backcrossed to C57BL/6 mice for at least six to eight generations. The F1 progeny 
homozygous for the floxed allele (Twsg1fl/fl) was crossed with Twsg1wt/kovav::iCre 
mice to generate mice with a conditional loss of Twsg1 in the hematopoietic cell 
compartment (Twsg1fl/KOVav::iCre; designated as Twsg1cKO here). Mice carrying 
conditional allele (Bmp7fl/+) 38 were backcrossed into C57Bl/6 mice for at least seven 
generations.  The F1 progeny homozygous for the floxed allele (Bmp7fl/fl) was crossed 
with Bmp7wt/∆vav::iCre mice to generate mice with a conditional loss of Bmp7 in the 
hematopoietic cell compartment (Bmp7fl/∆vav::iCre; designated as Bmp7cKO here). 
Congenic C57Bl/6-CD45.1 mice were provided by A.Potocnik (NIMR, London, UK). 
Mice were maintained at the B.S.R.C. Al. Fleming animal facility under specific 
pathogen free conditions. Experiments on live animals were approved by the Hellenic 
Ministry of Rural Development (Directorate of Veterinary Services) and by BSRC 
Alexander Fleming’s Animal Research and Ethics Committee for compliance to 
Federation of European Laboratory Animal Science Associations’ regulations. 
 
LacZ staining and immunohistochemistry  
O.C.T. (BDH) embedded tissues were ‘snap frozen’ in liquid nitrogen steam. 6-7µm 
cryostat sections were placed in gelatin-coated slides, air-dried, fixed in cold 
gluteraldehyde/formaldehyde or PFA/acetone and incubated with 2mg/mL X-gal (HT 
Biotechnology, Cambridge, UK) at 37°C overnight. Subsequent staining was 
performed with the following antibodies CD3 (KT3), CD25 (7D4), CD205 
(DEC205)(NLDC)(all Biolegend, eBiosciences or BD Biosciences), Cytokeratin-8 
(CK8)(Troma-1, DSHB, Iowa). Sections were developed using an appropriate ABC-
HRP kit (Vector Laboratories, Burlingame, CA). 
 
Flow cytometry and sorting 
For surface antigens, staining was performed using standard procedures. The 
following antibodies were used CD4 (GK1.5, PECy5.5), CD8 (53-6.7, PE), Ly6C 
(AL-21, FITC), CD31 (390, biotin), B220 (RA3-6B2, PE), CD19 (6D5, APC), CD25 
(PC61, Alexa-700), cKIT (2B7, PE-Cy7), FITC), CD45.1 (A20, APC-Cy7), CD45.2 
(104, Alexa-700) (all Biolegend, eBioscience, or BD Biosciences), IgM (goat F(ab’)2 
(Southern Biotech). For FDG detection, labeled cells were incubated under hypotonic 
conditions with 2mM FDG (Marker Gene Technologies) at 37°C for 1min. Aquistion 
was on FACS CantoIITM using FACSDIVATM software (BD Biosciences). Analysis 
was performed using FlowJoTM (TreeStar). DN thymocytes were sorted as lineage 
negative (CD4-, CD8-, CD11b-, CD45RB-, CD49b-, TER119-) after depletion using 
the IMag mouse CD4 lymphocyte enrichment sets (BD Biosciences) followed by 
FACS sorting on a FACS Aria (BD Biosciences). 
 
Repopulation assay 
1x106 fetal liver cells from 15.5dpc Bmp7Δ/Δ embryos along with fetal liver cells from 
15.5dpc Bmp7+/Δ control embryos were injected into the tail-vein of the wt irradiated 
(1,038 rads) CD45.1 mice. At the age of 7-8 weeks mice were sacrificed and 
reconstitution was monitored by flow cytometric analysis of peripheral blood using 
CD45.1/CD45.2 to gate specifically on fetal liver derived cells. 
 
RT-PCR 
RNA was extracted from wild-type thymus, bone marrow, liver and kidney and sorted 
subpopulations using Trizol and concentrations were determined by 
spectrophotometry. For each fraction 2µg RNA was reverse transcribed into cDNA 
with superscript II (Invitrogen). RT-PCR was done with in a solution containing 
1.2µL MgCl2, 4.0µL mixture containing dNTPs, 1.0µL primer mix, 0.5µL Taq 
polymerase (Invitrogen). Cycling conditions were as follows: 94°C for 5min, then 35 
cycles of 94°C for 20sec, 60°C for 30sec and 72°C for 90 sec. For primer sequences 
see supplemental methods. 
 
Statistical Analysis 
Student’s t-test was used for statistical analysis. Results with a P value of less than 
0.05 were considered significant. 
 
 
RESULTS  
Multiple components of the Bmp signaling pathway are expressed in primary 
hematopoietic organs 
To be able to address the potential role of Bmp signaling for lymphopoeisis we first 
assessed the expression of various Bmp and Bmp antagonists in primary lymphoid 
organs. RT-PCR analysis showed that Bmp2, Bmp4, Bmp5, Bmp6, and Bmp7 were all 
expressed in bone marrow whereas Bmp6 expression was not detectable in adult 
thymocytes. cDNAs from lung and kidney were used as positive controls for the PCR 
(Fig 1A). Similarly, expression of several Bmp antagonists was found both in thymus 
and bone marrow, namely Gremlin, Twsg1, and Chordin. Noggin expression was 
restricted to the bone marrow and was not detected in the thymus and (Fig. 1A). The 
analysis of FACS purified thymocyte sub-populations by RT-PCR revealed that both 
Bmp7 and Twsg1 were expressed in all thymocyte subsets investigated, with 
somewhat stronger expression in the DN fractions. To confirm these findings we also 
used lacZ reporter mice to assess gene expression in thymocyte subsets by flow 
cytometry. We detected expression of Twsg1 in DN, DP, CD4 and CD8 thymocyte 
subsets with the relative highest signal in the DN cell compartment (Fig. 1C). FDG-
based expression analysis, however, proved not to be sensitive enough to detect Bmp7 
expression in the T cell compartment (Fig. 1D). As expected no expression could be 
detected for Bmp4 and Gremlin (not shown). 
The expression of Bmp/Bmp antagonists also in thymocytes suggests that Bmp 
signaling might be actively regulating thymopoiesis.  
 
Compartmentalisation of Bmp/BMP antagonist expression in the adult thymus  
To reveal the spatial distribution of the various Bmp/Bmp antagonists within the adult 
thymus we analyzed lacZ reporter mice for Bmp4, Bmp7, Gremlin, and Twsg1. 
Double staining was performed for LacZ and DEC-205 (CD205) or cytokeratin 8 
(CK8) to distinguish between thymic cortex and medulla respectively (Fig. 2). The 
topology of expression was clearly different for every gene and was typically seen 
both in the medulla and the cortex. A more systematic analysis of lacZ expression in 
relation to cell surface markers was performed, which is summarized in Fig. 3 and 4. 
Bmp4 was mainly expressed in the vessels of the cortical region as well as in the sub-
capsular region of the thymus (Fig. 3A-D) but not in the medullary area where single-
positive CD4 or CD8 T cells reside. Bmp4 does not colocalize with CD25+ 
thymocytes in the cortical region (Fig. 3A, B) but was observed in dendritic cells and 
cortical thymic epithelial cells (Fig. 3C, D). Bmp7 was expressed both in the cortex 
and in the medulla. Expression was seen in some CD25+ cells (Fig. 3F) but not in 
CD3+ T cells (Fig. 3E), Furthermore, some dendritic cells and some CK8+ cortical 
thymic epithelial cells expressed Bmp7 (Fig. 3G, H). Twsg1 is abundantly expressed 
in both cortex and medulla of the adult thymus. It is seen in a few CD3+ cells in the 
medulla (Fig. 4A) as well as in CD25+ progenitor cells in the cortex (Fig. 4B). 
Dendritic cells and cortical thymic epithelial cells (Fig. 4C-D) also express Twsg1. 
Gremlin is also expressed in the cortex and medulla of the adult thymus. Expression 
was observed in dendritic cells and few cortical thymic epithelial cells, but not in T 
cells or their progenitors (Fig. 4E-F).  
 
Bmp/Bmp antagonist expression in the bone marrow 
To complement the expression data in thymocytes we performed flow cytometry-
based lacZ-expression analysis also on isolated bone marrow cells. We used Ly6C 
and CD31 to distinguish blast-like cells, lymphoid cells, myeloid cells, erythrocytes, 
granulocytes, and monocytes 39. Bone marrow cells from Bmp7-lacZ mice showed 
weak FDG staining in a subset of lymphoid cells (Fig. 5B). No significant expression 
of Bmp4 was observed (Fig. 5A). Twsg1 expression was detected in nearly all subsets 
with highest expression in lymphoid cells, monocytes, and granulocytes (Fig. 5C). 
Gremlin expression was detected in erythroid cells, granulocytes, and monocytes. 
Expression in cells of lymphoid origin varied and was not significant (Fig. 5D). Thus, 
the expression of various Bmp/Bmp antagonists in different hematopoietic cell 
subsets strongly suggests that Bmp signaling plays an active role in hematopoiesis.  
A more detailed analysis on expression in various B-cell subsets revealed as expected 
no expression for Bmp4 but also no clear expression for Bmp7. In contrast, expression 
of Twsg1 was dynamic, with peak expression seen in pro B-cells. Some Twsg1 
expression was also visible in the pre-pro subset and mature B-cells (Fig. 5B). The 
expression of Gremlin was quite variable and significant expression was only 
observed in mature B-cells (Fig. 5B).  
 
Steady state lymphopoiesis is unperturbed in Bmp7fl/∆vav::iCre mice 
Subsequently, we focused our analysis on two members of the Bmp signaling family, 
Bmp7 and Twsg1, and asked whether their deletion from all hematopoietic cells would 
affect steady-state lymphopoiesis in vivo. For this we generated mice lacking Bmp7 in 
all hematopoietic cells (Bmp7cKO) by crossing a conditional Bmp7 allele 38 to the 
vav::iCre deleter line 40. Bmp7cKO animals had normal weight and appeared healthy. 
Analysis of 4-6 weeks old mice revealed that deletion of Bmp7 had no apparent 
effects on thymocyte development. The numbers and percentages of progenitor DN, 
DP, CD4 SP and CD8 SP thymocyte subsets were not significantly altered when 
compared to littermate control mice (Fig. 6A). Analysis of the BM from 6-8 weeks 
mice showed that the cell counts of blast-like cells, erythroid cells, granulocytes, 
lymphocytes, monocytes, and myeloid cells were all normal when compared to 
control mice (Fig. 6B). To extend our studies we next transplanted fetal liver cells 
from 15.5dpc Bmp7-null or control embryos in lethal irradiated, allotypically marked 
recipient mice. Bmp7-deficient mice, obtained by germline deletion of the Bmp7fl/fl-
allele (Bmp7Δ/Δ, 38) survive beyond the embryonic stage E15.5. Transfer of Bmp7-null 
cells resulted in >80% reconstitution of recipient’s immune system by 7-8 weeks. 
Absence of Bmp7 did not result in any apparent defects of thymocyte subsets. 
Similarly, analysis of BM cells revealed unperturbed populations of blast cells, 
erythroid cells, granulocytes, lymphocytes, monocytes and myeloid cells (Fig. S1). 
Taken together, the results obtained by a lineage specific deletion of Bmp7 and by the 
transplantation of fetal Bmp7-null progenitors reveals that Bmp7 secretion from any 
hematopoietic subset is dispensable for lymphopoiesis per se.  
 
Steady state lymphopoiesis is unperturbed in Twsg1fl/KOvav::iCre mice 
Twsg1, similar to Bmp7, is expressed both by thymocytes and by thymic stroma cells. 
In vitro analyses have shown that Twsg1 regulates thymocyte development at the DN 
and DN to DP transitional stage 26, 27. As Twsg1-deficient mice display defects in 
lymphopoiesis 41 we sought to determine whether these defects are due to lack of 
Twsg1 in the lymphoycte precursor cells or the respective stroma cells. For this we 
generated mice lacking Twsg1 in all hematopoietic cells (Twsg1cKO) by crossing a 
conditional Twsg1fl/fl allele 37 to the vav::iCre deleter line 40. Twsg1cKO animals 
appeared normal and remained healthy for up to 10-12 months. Analysis of thymocyte 
subsets from 4-6 weeks old Twsg1cKO or control mice by flow cytometry revealed 
that absence of Twsg1 in the hematopoietic cell subset did not affect thymocyte 
development. The DN, DP, as well as CD4 SP and CD8 SP thymocyte subsets were 
not altered (Fig. 7A). This indicated that lack of stroma-derived rather than 
thymocyte-derived Twsg1 is responsible for the lymphoid defects observed in Twsg1-
deficient mice 41. Similarly, analysis of bone marrow cells from 6-8 weeks mice 
showed that the relative number of blast-like cells, erythroid cells, granulocytes, 
lymphocytes, monocytes, and myeloid cells was not altered (Fig. 7B). Moreover, 
analysis of developing B cells showed that pre-pro (B220+/CD19-/cKIT-/CD25-/IgM-), 
pro (B220+/CD19+/cKIT+/CD25+/IgM-), pre (B220+/CD19+/cKIT-/CD25+/IgM+), 
immature (B220+/CD19+/cKIT-/CD25-/IgM+) cells remained unaltered (Fig. 7C). 
These data indicate that despite its abundant expression in thymocytes and B-
lymphocyte precursors, lymphopoiesis is not critically dependent on Twsg1-
expression in the hematopoietic compartment.  
 
Discussion 
The importance of Bmp signaling for the development and homeostasis of thymus and 
bone marrow is clearly documented 6, 24, 26, 28, 41. Several different Bmps (Bmp2, 
Bmp4, Bmp5, Bmp6 and Bmp7) and Bmp antagonists (Noggin, Gremlin, Twsg1, and 
Chordin) are expressed both in thymus and the bone marrow. Using LacZ reporter 
mice for several Bmp/Bmp antagonists in combination with histochemistry we have 
mapped expression of Bmp4, Bmp7, Gremlin, and Twsg1 in the thymus and 
developing lymphocytes revealing highly unique expression pattern for every gene 
analysed. Bmp4 was mainly expressed along vessels of the cortical region as well as 
in the sub-capsular region of the thymus but not in the medullary area where single 
positive T cells reside. Quite in contrast Bmp7 expression was observed both in the 
cortex and in the medulla, in epithelial cells, dendritic cells, as well as some 
developing lymphocytes. Both Twsg1 and Gremlin were abundantly expressed in 
cortex and medulla. Expression of both molecules was noted in epithelial cells and 
dendritic cells. As expected, Twsg1 was also found in developing thymocytes. It is 
noteworthy that Twsg1 expression in the cortex was not uniform but confined to 
distinct areas. This could indicate a hitherto unrecognized functional 
compartmentalization of the thymic cortex. Twsg1 might also differentially affect 
CD4 and CD8 T-cells. We frequently observed CD3+ T-cells in close vicinity to 
Twsg1+ medullary stroma cells we never saw this for CD8+ T-cells. Though we 
mapped expression for only a few Bmp/Bmp antagonists, this limited survey was 
sufficient to indicate an unexpected complexity of Bmp signaling in the adult thymus 
where multiple Bmp signaling networks regulate thymus homeostasis and thymocyte 
development. With respect to the thymocytes, Bmp/Bmp antagonist expression 
appeared compartmentalised in cortical and medullary areas of the thymus suggesting 
that Bmp signals might affect all stages of T-cell development.  
Relatively little is known about how BMP signals regulate the various aspects of 
thymocyte differentiation 42. In vitro experiments have established that BMP2/4 
negatively affect the transition from the DN2 to the DN3 and from the DN to the DP 
stage. Addition of exogenous BMP antagonists such as Noggin or Chordin/Twisted 
Gastrulation reversed these effects 26, 27. Thus, the balance between BMP/BMP 
antagonists might regulate T-cell development within the various thymic 
microenvironments in vivo. Thereby, BMP signals could be acting on thymocytes 
directly or indirectly via the thymic stroma.  
One prominent example involving direct signaling of Bmps is their regulation of Id 
(Inhibitor of differentiation) gene expression 43. Ids inhibit the E-proteins E47 and 
E12, two important regulators of thymocyte development. Ids have also been mapped 
downstream of TCR signaling 44. Overexpression of a dominant negative form of Id3 
in human T lineage precursor cells blocks early T cell development 45. In addition, the 
observation that the BMP antagonist Twsg1 is upregulated following preTCR 
engagement 26 might also be regarded as evidence for a direct effect of Bmp signals 
on developing thymocytes. As the degradation of E-proteins is regulated by Notch 
signaling 46, Id/E protein activity might be a major inegration platform of various 
major signaling pathways.  
Futhermore, Bmps appear to be important regulators of the thymic stroma per se 6 
acting mainly indirectly by engaging several cellular signaling pathways. This can be 
achieved in part through regulating FoxN1 gene expression as was shown for the 
embryonic thymic stroma 47. Whether this mechanism also operates in the adult 
thymus needs to be shown. Comparisons with other organs would indicate that Bmp 
signaling can interact with all major developmental signaling pathways such as Notch, 
wnt/b-catenin, Hh and FGF. All these pathways have established roles in thymus and 
thymocyte development on their own6-9, but comparatively little is known on 
reciprocal interactions between these pathways. Interestingly, Bmp4 reportedly can 
modulate FGF7/FGF10 24 in the thymic stroma. In addition, BMP signals might also 
interfere with cytokine signaling, as shown for Bmp4, which negatively regulates IL-
7-mediated development of thymic progenitor cells 28.  
With respect to Bmp/Bmp antagonist expression in developing thymocytes only Bmp7 
and Twsg1 were detected. They were expressed in all thymocyte subsets investigated, 
and for both expression was strongest in DN thymocyte subsets. Twsg1 expression in 
DN thymocyte subsets had been reported previously 26, 28. In this report we show 
Twsg1 is also expressed in DP, CD4SP, and CD8SP thymocytes. Twsg1 can be 
induced in DP thymocytes in a TCR-dependent manner 26, thus its expression might 
reflect their. Twsg1 was also dynamically expressed in various subsets of developing 
B-cells. Highest expression was observed in pro B-cells, which like the DN2 
thymocyte population is known to require cytokine survival signals, most 
prominantely IL-7 48, 49. As Bmp4 can counteract this IL-7-induced proliferation and 
differentiation 28, Twsg1 expression in these subsets could serve to overcome a Bmp-
mediated proliferative block, similarly to its role in regulating the DN to DP transition 
in thymocytes 26. Twsg1 was also expressed in all other hematopoietic subsets 
analyzed indicating a function for Bmp signaling also for their development. 
The expression of Bmp7, which was strongest in the DN3/DN4 thymocyte subsets, 
could not be confirmed in thymocytes or bone marrow cells using the Bmp7-lacZ 
reporter mouse 34. Possible explanations for this might be low expression and/or 
insufficient sensitivity of the lacZ reporter line caused by the incidental disruption of 
a lymphocyte specific enhancer when inserting the lacZ gene into the Bmp7 locus or 
alternatively, by the silencing of promoter structures instigated by the presence of the 
lacZ gene.  
 
In the BM Bmp signaling has mainly been associated with a role in regulating the 
stem cell-niche synapse 50. The expression of Bmp7, Twsg1, and Gremlin in 
developing hematopoietic cells would therefore suggest that Bmp signaling regulates 
the maturation of all hematopoietic cell lineages. This might be direct by regulating 
their development or indirect by providing signals to their niche or to the close 
cellular environment.  
In the thymus developing lymphocytes need to interact with thymic stroma cells for a 
functional organ to develop 29. Thus, the necessity for reciprocal crosstalk is well 
established in this organ. Thymic epithelial cells are constantly regenerated from a 
pool of stem/progenitor cells in the adult thymus making the thymus a much more 
dynamic structure than previously assumed 51. It has been shown that Bmp signals 
maintain the expression of the critical FoxN1 gene in embryonic thymic stroma 47. 
Currently, it is not known whether in the adult thymus FoxN1 expression is also 
regulated by Bmp signals, and if yes, what is the identity and source of this Bmp 
signal. It will be of particular interest to establish whether lymphocyte-derived 
derived Bmp signals participate in this process. 
Bmp7-deficient mice are not viable 38, 52, 53 and the in vivo requirements for Twsg1 are 
background dependent. Whereas Twsg1-deficient mice are viable and show impaired 
lymphocyte development on some genetic backgrounds 41, about 44% of Twsg1 null 
mutants on the C57Bl6 background die in utero and display craniofacial 
malformations of variable severity (37, and own observations). Conditional deletion of 
Bmp7 and Twsg1 in all hematopoietic cells using the vav::iCre resulted in viable and 
healthy mice with normal cellularity of the lymphoid organs. We also analyzed 10-12 
months old Bmp7cKO and Twsg1coKO mice to assess potential late-onset effects, but 
still did not observe any alterations to the hematopoietic compartments (data not 
shown). This indicated that bone-marrow stroma derived Twsg1 rather than 
hematopoietic cell derived Twsg1 might be responsible for the lymphoid defects 
observed in Twsg1 null mice 41.  
To extend these results we transplanted Bmp7-deficient fetal liver cells into lethally 
irradiated wild type recipients, which revealed that Bmp7 was even dispensible for the 
development of embryonic hematopoietic stem cells. Taken together, these data 
suggest that although Twsg1 and Bmp7-are dynamically expressed in lymphoid and 
some myeloid cells, they appear to be redundant for steady-state lymphoid and 
myeloid development. How can this be reconciled with published in vitro data where 
Twsg1 has been shown to counteract Bmp2/4, which are both negative regulators of 
lymphopoiesis 26-28? One obvious possibility is their compensation from other cellular 
sources or functional redundancy. Stroma cells also produce Twsg1 and Bmp7. This 
compartment is seemingly the critical contributor of Twsg1 in vivo given the overall 
undisturbed lymphopoiesis in Tswg1fl/flvav::iCre animals. Since Bmp7-deficient 
animals die in late gestation or shortly after birth 38 we have no information on its role 
for T- or B-cell development. Some preliminary analysis of fetal Bmp7-deficient 
thymi indicates altered thymocyte development in the absence of Bmp7 (O. Passa and 
D. Graf, unpublished). Compensation by other Bmps, such as Bmp5 or Bmp6 that 
belong to the same Bmp subgroup (glass-bottom-boat orthologues) is also a 
possibility. In contrast, a functional compensation by Bmp2/4 (decapentaplegic 
orthologues) is less likely, as Bmp7 itself did not recapitulate the inhibitory effects of 
Bmp2/4 on thymocyte proliferation and differentiation 26. Why would developing 
lymphocytes express Bmp/Bmp antagonists if their function appears to be redundant? 
Our analysis of Twsg1- and Bmp7-deficiency was restricted to steady state lymphoid 
development. Even if lymphoid development per se is not affected, the functional 
properties of the mature B- and T-cells might be altered in their absence. For instance, 
B-cell derived Twsg1 is not required for B-cell development per se, but is involved in 
regulating T-cell independent plasma B-cells production and function 54. Thus, Bmp 
signaling might fine-tune lymphocyte development, which could be achieved by 
altering cytokine or TCR/BCR signaling thresholds. In consequence, absence of these 
molecules might affect repertoire selection or recruiting into different functional 
subsets. On the other hand, thymic epithelial cells might also be targets of lymphocyte 
derived BMP signals. Both cortical and medullary epithelial cells are continuously 
replenished from epithelial stem/precursor cells 51. It is thus feasible that lymphocyte-
derived BMP signals are part of the thymocyte-thymic stroma crosstalk and contribute 
to the maintenance of a functional thymus. 
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FIGURE LEGENDS 
 
Figure 1. Expression of Bmp/Bmp antagonists in primary lymphoid organs. (A) 
RT-PCR analysis of Bmps, Bmp antagonists in the thymus and bone marrow. Lung 
and kidney served as positive controls. (B) Bmp7 and Twsg1 expression on FACS 
sorted DN2-4, DP, SP CD4 and SP CD8 thymocyte populations. (C-D) FDG based 
quantitative analysis of lacZ gene reporter activity by FACS on thymocyte 
subpopulations from Twsg1-lacZ (C), Bmp7-lacZ (D) and wt control mice showing 
significant levels of expression for Twsg1 in the SP CD4, SP CD8, DP and DN 
compartments in the thymus (n=9 mice per group), while no significant differences 
were detected for Bmp7 (n=5 mice per group). MFI, Mean Fluorescence Intensity, * 
p<0.05. 
 
Figure 2. Bmp/Bmp antagonist expression in cortex and medulla of the thymus. 
(A-D) X-gal based detection of lacZ gene reporter activity for Bmp4 (A), Bmp7 (B), 
Twsg1 (C), Gremlin (D)(blue) on thymus sections combined with 
immunohistochemical staining for DEC-205 (CD205, NLDC; brown) to indicate 
cortical and medullary areas. c, cortex; m, medulla; sc, subcapsular zone. (size bar 
50µm). 
 
Figure 3. Identity of Bmp4 and Bmp7 expressing cells in the thymus. X-gal based 
detection of lacZ gene reporter activity for Bmp4 (A-D) and Bmp7 (E-H) (blue) on 
thymus sections combined with immunohistochemical staining for for CD3 (A, E), 
CD25 (B, F), DEC-205 (C, G), Cytokeratin8 (CK8) (D, H) (red or brown). c, cortex; 
m, medulla; sc, subcapsular zone. (size bar 50µm). 
 Figure 4. Identity of Twsg1 and Gremlin expressing cells in the thymus. X-gal 
based detection of lacZ gene reporter activity for Twsg1 (A-D) and Gremlin (E-H) 
(blue) on thymus sections combined with immunohistochemical staining for for CD3 
(A, E), CD25 (B, F), DEC-205 (C, G), CK8 (D, H) (red or brown). c, cortex; m, 
medulla; sc, subcapsular zone. (size bar 50µm). 
 
Figure 5. Bmp7, Twsg1 and Gremlin are expressed in hematopoietic cells in the 
BM. (A) FDG based quantitative analysis of lacZ gene reporter activity of Bmp4, 
Bmp7, Twsg1, and Gremlin by FACS on bone marrow subpopulations identified by 
Ly6C/CD31 staining55.(A) or B-cell subpopulations identified by 
B220/CD19/cKIT/CD252 (B). (A) Significant expression for Bmp7 was observed in 
lymphoid cells (n=4 mice per group), for Twsg1 in erythroid cells, granulocytes, 
lymphoid, and myeloid cells as well as monocytes (n=5 mice per group), for Gremlin 
in the erythroid cells, granulocytes and monocytes (n=4 mice per group), while no 
expression of Bmp4 was detected (n=4 mice per group). (B) Significant expression 
for Twsg1 was observed in pre-pro (B220+/cKIT-/CD19-), pro 
B220+/CD19+/cKIT+/CD25+) and B cells (B220+/CD19+/cKIT-/CD25-) while Gremlin 
expression was limited to B cells (B220+/CD19+/cKIT-/CD25-). Bl, Blasting cells; L, 
Lymphocytes; E, Erythrocytes; My, Myeloid precursor cells; G, Granulocytes; Mo, 
Monocytes; MFI, Mean Fluorescence Intensity, * p<0.05. 
 
Figure 6. Normal lineage distribution in Bmp7cKO mice in thymus and BM. 
Analysis of thymocyte (A) and bone marrow (B) subpopulations and graphical 
representation of cell numbers from Bmp7cKO and littermate control mice. (n=4 mice 
per group). The results are representative for more than 3 independent experiments. 
(A) Thymocyte populations were detected by CD4/CD8 staining and gated as DN, 
DP, CD4SP, CD8SP subpopulations. (B) Bone marrow populations were detected by 
CD31/Ly6C staining55. Percentages and total numbers of the various subsets were 
unaltered (n=4 mice per group). The results are representative for more than 3 
independent experiments. Bl, Blasting cells; L, Lymphocytes; E, Erythrocytes; My, 
Myeloid precursor cells; G, Granulocytes; Mo, Monocytes 
 
 
Figure 7. Normal lineage distribution in Twsg1cKO mice in thymus and BM. 
Analysis of thymocyte (A) and bone marrow (B) subpopulations and graphical 
representation of cell numbers from Twsg1cKO and littermate control mice. (n=3 
mice per group). The results are representative for more than 3 independent 
experiments. (A) Thymocyte populations were detected by CD4/CD8 staining and 
gated as DN, DP, CD4SP, CD8SP subpopulations. (B) Bone marrow populations 
were detected by CD31/Ly6C staining55. Percentages and cell numbers of the various 
subsets were unaltered (n=4 mice per group). The results are representative for more 
than 3 independent experiments. (C) B-cell subpopulations identified by 
B220/CD19/cKIT/CD25/IgM staining2. Percentages and cell numbers of the various 
subsets were unaltered (n=3 mice per group). Bl, Blasting cells; L, Lymphocytes; E, 
Erythrocytes; My, Myeloid precursor cells; G, Granulocytes; Mo, Monocytes  
  
 
 
 
 
 
 
Figure S1. Normal lineage distribution of Bmp7∆ /∆  cells  after BM 
transplantation of E15.5 fetal liver Bmp7∆ /∆  cells .  Analysis of thymocyte 
(A) and bone marrow (B) subpopulations and graphical representation of cell numbers 
from Bmp7cKO and littermate control mice. (n=4 mice per group). (A) Thymocyte 
populations were detected by CD4/CD8 staining and gated as DN, DP, CD4SP, 
CD8SP subpopulations. (B) Bone marrow populations were detected by CD31/Ly6C 
staining and gated as described50. Percentages and cell numbers of the various subsets 
were unaltered (n=4 mice per group). Bl, Blasting cells; L, Lymphocytes; E, 
Erythrocytes; My, Myeloid precursor cells; G, Granulocytes; Mo, Monocytes 
 








